H7N7 Influenza-A Virus Netherlands/219/03 Recombinant, H7N7 Netherlands, 10ug

CAT No.BT-IHA-009

H7N7 Influenza-A Virus Netherlands/219/03 Recombinant, H7N7 Netherlands, 10ug

---

Description
Recombinant Full-Length H7N7 A/Netherlands/219/03 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 70,000 Dalton.

Formulation

The Recombinant H7N7 A/Netherlands/219/03 solution contains 10mM Sodium phosphate, pH 7 and 150mM NaCl.

Immunological Activity
Western-Blot 0.1ug -1ug per strip, ELISA 1ug/Well.

Sterile Filtered colorless solution FormulationThe Recombinant H7N7 A/Ntherlands/219/03 solution contains 10mM Sodium phosphate, pH 7 and 150mM NaCl.

Purity
Greater than 90.0% as determined by SDS-PAGE.

Source
Baculovirus Insect Cells.

Stability
H7N7 A/Netherlands/219/03 Recombinant should be stored at 4¡ãC.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.